Table 1.
P-PMO name | P-PMO sequence (5′–3′) | Nucleotide position of P-PMO target in PPRSV RNA, and P-PMO orientation | P-PMO target region in PRRSV |
---|---|---|---|
5UP1 | CATAGAGCCAACACCTATACG | 3–23, antisense | 5′-terminus of genomic RNA |
NSP1 | CCCAAAAACTTGCTGCACGG | 66–85, sense | 3′-end-region of negative-sense (antigenome) RNA |
TRS-Pc,d | GACATGGTTAAAGGGGTGGAG | 173–193, antisense | TRS-region and 5′-end of ORF1a |
TRSsg-Pd | GGTTAAAGGGGTGGAGAGACCG | 167–188, antisense | TRS and TRS 5′-flanking sequence |
ORF1aPc | CCGATCAAGTATCCCAGACAT | 189–209, antisense | Translation initiation region of ORF1a |
3UP1 | GTCGCCCTAATTGAATAGGTG | 15032–15052, antisense | 3′-end-region of genomic RNA |
CP1 | GATATACACAACACCCAATT | None | Random sequence negative control |
The peptide R5F2R4 is conjugated to the 5′-end of all the P-PMOs in this study.
P-PMO design was based on PRRSV VR2385 genomic RNA.
The underlined nucleotides correspond to the AUG translation initiation codon of PRRSV ORF1a.
The italicized nucleotides correspond to the ‘transcription regulatory sequence’.